KKKai Kitamura

Kai Kitamura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kai Kitamura has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Photoaffinity Labeling Strategy Reveals Tetraspanin CD9 as a Transient Target of Anticancer Yaku'amide B

    by Junhao Fu, Koichi Kamiya, Kai Kitamura, Ryo Kawahara, Wataru Shihoya, Osamu Nureki, Shoichi Hosoya, Reiko Nakagawa, Tetsuo Mashima, Hiroaki Itoh, et al.

    Innovative chemical strategies are needed to understand the molecular targets of natural products, especially when they engage with multiple targets via transient interactions. Yaku’amide B (1), an anticancer natural product, inhibits mitochondrial FoF1-ATP synthase with nanomolar affinity; however, this mechanism alone does not explain its unique activity. Here, we employed photoaffinity labeling (PAL), a powerful, key strategy, and discovered that tetraspanin CD9 is a transient cell surface target of 1 in cancer cells. Comprehensive analyses revealed that 1 binds to the cyto-plasmic N-terminal region of CD9 with micromolar affinity, thereby accelerating its cellular entry, inducing CD9 de-pletion via lysosomal proteolysis and inhibiting cancer cell migration. Thus, 1 represents the first natural product that binds to and promotes the degradation of CD9. This study underscores the versatility of applying the PAL strategy for mechanistic studies and establishes 1 as a novel molecular platform for targeting CD9-mediated cellular pathways.